- https:
//www.myastheniagravis.org/about-mg/treatments/ [last accessed November 2023] - https:
//www.ncbi.nlm.nih.gov/pmc/articles/PMC7484611/ [last accessed November 2023]
Biological Treatments
These therapies, called monoclonal antibodies, are administered intravenously and include Rituximab and Eculizumab. They target specific components of the immune system to reduce antibody levels and may be used alongside other treatments. They can be expensive and require routine transfusions.
If you are concerned about anything you have read in this article, please seek advice from your healthcare provider.
References
Reporting side effects
You can help by reporting any side effects you may get. By reporting side effects you can help provide more information on the safety of this medicine.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the patient information leaflet. You can also report side effects directly in the UK via the Yellow Card Scheme website: https://yellowcard.mhra.gov.uk or via the MHRA Yellow Card App in the Google Play or Apple App Store. In Ireland please report via the HPRA at https://www.hpra.ie/homepage/about-us/report-an-issue.
You can also report adverse events to UCB at UCBCares.UK@ucb.com or UCBCares.IE@ucb.com